Results 131 to 140 of about 14,564 (189)

Efficacy and safety of ranibizumab, aflibercept, and conbercept in the treatment of diabetic macular edema: a retrospective comparative study. [PDF]

Sci Rep
Liu B, Qiao Q, Dang Y.
europepmc   +1 more source

Adverse Events Reported with Standard-Dose and High-Dose Aflibercept: A FAERS Pharmacovigilance Study. [PDF]

Vision (Basel)
Prasad M, Ramsey DJ.
europepmc   +1 more source

Switching to High-Dose Aflibercept (8 mg) with Pro Re Nata Reduces Treatment Burden in Diabetic Macular Edema: A Real-World Pilot Study. [PDF]

J Clin Med
Funatsu M, Higashijima F, Ariyoshi N, Haraguchi A, Wasai Y, Mikuni M, Ohta M, Wakuta M, Hirano S, Yamauchi K, Kimura K.   +10 more
europepmc   +1 more source

Ocular Half-Life: What it Does and Does Not Mean for Intravitreal Anti-angiogenic Drug Durability. [PDF]

Ophthalmol Ther
Avery R, Diack C, Holekamp N, Lhor M, Mar F, Maass K.   +5 more
europepmc   +1 more source

Measurement of Acute Intraocular Pressure Elevation Immediately After Intravitreal Anti-VEGF Injection and Analysis of Prefilled Syringe Accuracy. [PDF]

Clin Ophthalmol
Itoh K, Negishi M.
europepmc   +1 more source

Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema: 1-Year Results from the China RHINE Subpopulation. [PDF]

Ophthalmol Ther
Li X, Liu X, Jiang Q, Wu Z, Han M, Chen Q, Idowu OO, Liu R, Liu W, Willis JR, Sun X.   +10 more
europepmc   +1 more source

Lower Rates of Intraocular Inflammation with Aflibercept 8 mg Delivered via Pre-Filled Syringe Versus Vial. [PDF]

Ophthalmol Ther
Hoffmann L, Hatz K.
europepmc   +1 more source

Reducing the Carbon Footprint of Neovascular Age-Related Macular Degeneration Therapy: Environmental Impact of Transitioning to Aflibercept 8 mg. [PDF]

J Ophthalmol
Veritti D, Misciagna M, Teatino C, Pontoni C, Blasutig M, Kuftic M, Pece S, Morsanutto A, Pece A, Lanzetta P.   +9 more
europepmc   +1 more source

Retinal vein occlusion-related macular edema: An updated review of current evidence and future directions. [PDF]

Indian J Ophthalmol
Temkar S, Rajasekar G, Shah AD, Shaikh N, Deb AK, Basa K.   +5 more
europepmc   +1 more source

Fellow-eye effect of intravitreal aflibercept 8mg in a patient with bilateral refractory nAMD: a case report and literature review. [PDF]

BMC Ophthalmol
Zhang J, Zhang F, Wang P, Lin B, Yang M, Chen Q.   +5 more
europepmc   +1 more source